Drug-induced lupus erythematosus
| Drug-induced lupus erythematosus | ||
| ICD-10 | M32.0 | |
|---|---|---|
| ICD-9 | 710.0 | |
| OMIM | 152700 | |
| DiseasesDB | 12782 | |
| MedlinePlus | 000435 | |
| MeSH | C17.300.480 | |
|
Drug-induced lupus erythematosus Microchapters |
|
Differentiating Drug-induced lupus erythematosus from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug-induced lupus erythematosus On the Web |
|
American Roentgen Ray Society Images of Drug-induced lupus erythematosus |
|
Directions to Hospitals Treating Drug-induced lupus erythematosus |
|
Risk calculators and risk factors for Drug-induced lupus erythematosus |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Drug-induced lupus erythematosus from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
Template:Diseases of the musculoskeletal system and connective tissue